Methods and systems for endobronchial diagnostics
Inventors
Mantri, Surag • Radhakrishnan, Srikanth
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
Methods and systems for targeting, accessing and diagnosing diseased lung compartments are disclosed. The method comprises introducing a diagnostic catheter with an occluding member at its distal end into a lung segment via an assisted ventilation device; inflating the occluding member to isolate the lung segment; and performing a diagnostic procedure with the catheter while the patient is ventilated. The proximal end of the diagnostic catheter is configured to be attached to a console. The method may also comprise introducing the diagnostic catheter into the lung segment; inflating the occluding member to isolate the lung segment; and monitoring blood oxygen saturation. The method may further comprise introducing the diagnostic catheter into the lung segment; determining tidal flow volume in the lung segment; determining total lung capacity of the patient; and determining a flow rank value based on the tidal flow volume of the lung segment and the total lung capacity.
Core Innovation
The disclosed system assesses the functionality of a lung segment using measurements of expiratory flow and total lung capacity. It relates average tidal expiratory volume to total lung capacity to inform a treatment option, and it evaluates collateral ventilation using expiratory-flow measurements obtained during assisted ventilation. The system further includes oxygen-saturation and oxygen-absorption assessments.
The collateral ventilation assessment uses either average expiratory air-flow volume versus time or average maximum air-flow magnitude to determine the degree of collateral ventilation. These resulting functional assessments inform treatment selection, including endoscopic lung volume reduction performed with a one-way endobronchial valve.
Claims Coverage
The three independent claims cover methods for assessing lung-segment functionality and determining a treatment option using flow-volume measurements and total lung capacity, presenting three inventive features.
Treatment selection using tidal flow volume and total lung capacity
The claim determines average tidal expiratory volume over a given number of cycles, determines total lung capacity, and bases a treatment option on the average tidal expiratory volume over total lung capacity.
Collateral ventilation assessment using average expiratory air-flow volume versus time
The claim assesses the degree of collateral ventilation based on average expiratory air-flow volume versus time during assisted ventilation, and determines a treatment option based on tidal flow volume and total lung capacity.
Collateral ventilation assessment using average maximum air-flow magnitude
The claim assesses the degree of collateral ventilation based on average maximum air-flow magnitude during assisted ventilation, and determines a treatment option based on tidal flow volume and total lung capacity.
The claims cover three related approaches to assessing lung-segment functionality by using tidal expiratory volume relative to total lung capacity to guide treatment, and using either average expiratory air-flow volume versus time or average maximum air-flow magnitude to assess collateral ventilation.
Stated Advantages
The disclosure states that ventilated collateral-flow assessment can take less than a minute, compared with 2 to 5 minutes for prior methods.
Documented Applications
Assessing lung-segment functionality and collateral ventilation to guide treatment selection, including endoscopic lung volume reduction with a one-way endobronchial valve.
Assessing oxygen saturation and oxygen absorption.
Interested in licensing this patent?